A Clinical Study To Assess The Safety And Effectiveness Of The OMNI® Surgical System

CompletedOBSERVATIONAL
Enrollment

70

Participants

Timeline

Start Date

September 1, 2021

Primary Completion Date

August 21, 2023

Study Completion Date

August 21, 2023

Conditions
Glaucoma, Open-Angle
Interventions
DEVICE

OMNI® Surgical System

The OMNI® Surgical System is indicated for canaloplasty (microcatheterization and transluminal viscodilation of Schlemm's canal) followed by trabeculotomy (cutting of trabecular meshwork) to reduce intraocular pressure in adult patients with primary open-angle glaucoma.

Trial Locations (4)

19406

Northern Ophthalmics, Jenkintown

62708

Grene Vision Group, Wichita

73112

Oklahoma Eye Surgeons, Oklahoma City

79902

El Paso Eye Surgeons, El Paso

All Listed Sponsors
lead

Sight Sciences, Inc.

INDUSTRY

NCT05044793 - A Clinical Study To Assess The Safety And Effectiveness Of The OMNI® Surgical System | Biotech Hunter | Biotech Hunter